Clinical relaxation: current controversy.
Savarese
J J
JJ
D015113:Androstane-3,17-diol / Q000008:administration & dosage / Q000031:analogs & derivatives; D000758:Anesthesia / Q000639:trends; D001279:Atracurium; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006801:Humans; D007442:Intubation, Intratracheal; D007546:Isoquinolines / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D000077590:Mivacurium; D009125:Muscle Relaxants, Central / Q000008:administration & dosage; D009388:Neostigmine / Q000627:therapeutic use; D009466:Neuromuscular Blocking Agents / Q000008:administration & dosage; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage; D010197:Pancuronium / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000378:metabolism; D017300:Pipecuronium; D010879:Piperazines / Q000008:administration & dosage; D014673:Vecuronium Bromide
D002800:Cholinesterase Inhibitors; D007546:Isoquinolines; D009125:Muscle Relaxants, Central; D009466:Neuromuscular Blocking Agents; D003473:Neuromuscular Nondepolarizing Agents; D010879:Piperazines; D017300:Pipecuronium; D015113:Androstane-3,17-diol; D001279:Atracurium; D009388:Neostigmine; D000077590:Mivacurium; D014673:Vecuronium Bromide; D010197:Pancuronium; C049429:doxacurium